Stay updated on Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial

Sign up to get notified when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 and removed Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T15:29:37.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-24T11:07:50.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The funding notice at the top of the page was removed, eliminating the warning about potential delays and outdated information due to funding gaps. This change affects the user's visibility of the page's operating status disclaimer.
    Difference
    0.2%
    Check dated 2025-11-17T06:07:20.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The Study Details page for NCT02227238 shows no additions or deletions to core content; the study overview, design, outcomes, and IPD sharing information remain as presented. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T00:45:45.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    1%
    Check dated 2025-10-05T08:04:14.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Version bump from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.0%
    Check dated 2025-09-28T03:00:41.000Z thumbnail image

Stay in the know with updates to Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.